Back to Agenda
Session 1: Future of Pharmacovigilance – Impact of Globalisation
Session Chair(s)
Doris Irene Stenver, MD, MPA
Independent Pharmacovigilance Adviser, Unique Advice, Denmark
Speaker(s)
Data and Evidence to Support Benefit Risk Decisions
Peter Richard Arlett, MD, FFPM, FRCP
Head Data Analytics and Methods Task Force, European Medicines Agency, Netherlands
Future of PRAC
Sabine Straus, MD, PhD, MSc
Former PRAC Chair, Medicines Evaluation Board (MEB), Netherlands
Pharmacovigilance Systems Strengthening – WHO Perspective
Shanthi Pal, DRSc, MPharm
Group Lead, Medicines Safety, Safety & Vigilance, WHO, Switzerland
Have an account?